Adimab

Adimab’s integrated antibody discovery and optimization platform offers unprecedented speed in delivering full-length human IgGs from antigen to purification. Adimab provides a fundamental advantage by delivering therapeutic-grade antibody panels that meet the most aggressive standards for affinity, epitope coverage, species cross-reactivity, and expressability. Adimab enables its partners to rapidly expand their biologics pipelines through broad technology access arrangements.